Literature DB >> 24233258

Early promising results for the endoscopic surgical treatment of Cushing's disease.

Mustafa Berker1, Ilkay Işikay, Dilek Berker, Miyase Bayraktar, Alper Gürlek.   

Abstract

High levels of endogenous cortisol due to Cushing's disease cause significant mortality and morbidity. Treatment of Cushing's disease is challenging. For many years, transsphenoidal microsurgical resection of the adenoma has been the treatment of choice. However, recently, neuroendoscope has taken its place in the neurosurgeon's armamentarium, and the endoscopic transsphenoidal resection of pituitary tumors has become a familiar approach. Our aim was to present the results of pure endoscopic surgery in the treatment of corticotropinomas for comparison with the results of previous endoscopic and microsurgical series. We present a retrospective analysis of 90 patients with diagnosis of Cushing's disease who were operated between 2006 and 2012. Among 90 patients, a total of 81 (90.0 %) had a remission (28 out of 29 macroadenomas (96.6 %) and 53 out of 61 microadenoma patients (86.9 %)). Of note is that 66 out of 69 (95.7 %) primary patients (i.e., those who were operated in our center) and 15 out of 21 (71.4 %) patients previously operated in other centers reached a hypo/eucortisolemic state. A remission rate comparable with previous endoscopic series was achieved. In nine patients, it was not possible to achieve remission at all. On the other hand, only four of our cases (5.6 %) had a recurrence, and with reoperation, all of these patients entered a re-remission. To our knowledge, our series is the largest series studying endoscopically operated adrenocorticotropic hormone-secreting adenomas. Our results suggest that the endoscopic approach has opened a new avenue in the treatment of Cushing's disease, previously a therapeutic challenge for both the clinician and the neurosurgeon. Endoscopic approach in the treatment of Cushing's disease is clearly better for patients because of its low morbidity rates and short duration of hospital stay. On the other hand, long-term follow-up of our patients will show whether these favorable observations will persist.

Entities:  

Year:  2013        PMID: 24233258     DOI: 10.1007/s10143-013-0506-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  36 in total

1.  Endoscopic endonasal pituitary surgery: evolution of surgical technique and equipment in 150 operations.

Authors:  H D Jho; A Alfieri
Journal:  Minim Invasive Neurosurg       Date:  2001-03

2.  Endoscopic endonasal transsphenoidal surgery.

Authors:  Paolo Cappabianca; Luigi Maria Cavallo; Enrico de Divitiis
Journal:  Neurosurgery       Date:  2004-10       Impact factor: 4.654

3.  Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.

Authors:  Jay Jagannathan; Rene Smith; Hetty L DeVroom; Alexander O Vortmeyer; Constantine A Stratakis; Lynnette K Nieman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

Review 4.  Pituitary adenomas: results of 684 surgically treated patients and review of the literature.

Authors:  H H Oruçkaptan; O Senmevsim; O E Ozcan; T Ozgen
Journal:  Surg Neurol       Date:  2000-03

5.  Early repeat surgery for persistent Cushing's disease.

Authors:  Z Ram; L K Nieman; G B Cutler; G P Chrousos; J L Doppman; E H Oldfield
Journal:  J Neurosurg       Date:  1994-01       Impact factor: 5.115

6.  The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.

Authors:  John R Lindsay; Edward H Oldfield; Constantine A Stratakis; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

7.  Biochemical predictors of outcome of pituitary surgery for Cushing's disease.

Authors:  R A Alwani; W W de Herder; M O van Aken; J H van den Berge; E J Delwel; A H G Dallenga; F H De Jong; S W J Lamberts; A J van der Lely; R A Feelders
Journal:  Neuroendocrinology       Date:  2009-11-12       Impact factor: 4.914

8.  Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.

Authors:  Joseph C T Chen; Aitun P Amar; SooHo Choi; Peter Singer; Wnluam T Couldwell; Martin H Weiss
Journal:  J Neurosurg       Date:  2003-05       Impact factor: 5.115

9.  Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).

Authors:  M A E M Wagenmakers; R T Netea-Maier; E J van Lindert; H J L M Timmers; J A Grotenhuis; A R M M Hermus
Journal:  Clin Endocrinol (Oxf)       Date:  2009-02       Impact factor: 3.478

10.  Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.

Authors:  Ilan Shimon; Zvi Ram; Zvi R Cohen; Moshe Hadani
Journal:  Neurosurgery       Date:  2002-07       Impact factor: 4.654

View more
  5 in total

Review 1.  Outcome of endoscopic vs microsurgical transsphenoidal resection for Cushing's disease.

Authors:  Nidan Qiao
Journal:  Endocr Connect       Date:  2018-01       Impact factor: 3.335

2.  Endoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a systematic review and meta-analysis.

Authors:  Leonie H A Broersen; Nienke R Biermasz; Wouter R van Furth; Friso de Vries; Marco J T Verstegen; Olaf M Dekkers; Alberto M Pereira
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 3.  Treatment challenges in pediatric Cushing's disease: Review of the literature with particular emphasis on predictive factors for the disease recurrence.

Authors:  Katarzyna Pasternak-Pietrzak; Elżbieta Moszczyńska; Mieczysław Szalecki
Journal:  Endocrine       Date:  2019-11-07       Impact factor: 3.633

4.  Outcomes of endoscopic transsphenoidal surgery for Cushing's disease.

Authors:  Zarina Brady; Aoife Garrahy; Claire Carthy; Michael W O'Reilly; Christopher J Thompson; Mark Sherlock; Amar Agha; Mohsen Javadpour
Journal:  BMC Endocr Disord       Date:  2021-03-03       Impact factor: 2.763

5.  The Past, Present, and Future Statuses of Formerly Classified "Atypical Pituitary Adenomas": A Clinicopathological Assessment of 101 Cases in a Cohort of More than 1,000 Pure Endoscopically Treated Patients in Single Center.

Authors:  Ercan Bal; İbrahim Kulaç; Selim Ayhan; Figen Söylemezoğlu; Mustafa Berker
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.